Medical Condition News

RSS

Four-gene signature may predict patients at higher risk of OSCC recurrence

Oral Squamous Cell Carcinoma (OSCC) is responsible for nearly a quarter of all head and neck cancers. It is one of the leading causes of cancer death - largely due to the failure of current histological procedures in predicting the recurrence of the disease. New research published in BioMed Central's open access journal BMC Cancer shows that a four-gene signature may accurately predict which patients are at higher risk of OSCC recurrence.

11 Oct 2011

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

11 Oct 2011

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma.

11 Oct 2011

FDA to review Banner's Bexarotene ANDA for CTCL skin cancer treatment

Banner Pharmacaps Inc. has confirmed that its Abbreviated New Drug Application for Bexarotene 75 mg soft gelatin capsules, a generic version of Targretin, has been accepted for review by the US Food and Drug Administration.

11 Oct 2011

Rare and severe hypoglycemia could be genetic

The life-threatening condition depicts the fact that the body does not have enough energy to function. Scientists at the University of Cambridge say mutations in the AKT2 gene are to blame. Writing in the journal Science, they say there are already cancer drugs which target a similar process.

10 Oct 2011

Merck’s diabetes combo pill gets FDA nod

The U.S. Food and Drug Administration (FDA) has approved Merck & Co.’s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).

10 Oct 2011

Targacept commences AZD3480 Phase 2b study in Alzheimer’s disease

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of a potential registration study of AZD3480 in mild to moderate Alzheimer's disease. The study is the subject of a Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration.

10 Oct 2011

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

10 Oct 2011

AIM at Melanoma applauds bill banning children from using indoor tanning beds

AIM at Melanoma, the largest international foundation dedicated to melanoma research and patient advocacy, applauds Governor Jerry Brown's signing today of Senate Bill 746, which now bans children under 18 from using indoor tanning beds. Tanning beds have been linked to the rapid rise in melanoma rates among 15-39 year olds.

10 Oct 2011

Ford researchers develop series of in-car health and wellness apps, services

Researchers at Ford have developed a series of in-car health and wellness apps and services aimed at monitoring people with chronic illnesses or medical disorders so they can manage their condition while on the go.

From Medtronic 10 Oct 2011

Beauty Encounter sponsors ACS's premier breast cancer event

Beauty Encounter, a premier online source for all things fragrance and beauty and specializing in hard-to-find niche products, sponsored the American Cancer Society's annual Making Strides Against Breast Cancer walk in the local Orange County event that took place on October 9, 2011 at the Segerstrom Center in Costa Mesa.

10 Oct 2011

Cannabis use leads to increased risk of depression in young people with specific genotype

Young people who are genetically vulnerable to depression should be extra careful about using cannabis: smoking cannabis leads to an increased risk of developing depressive symptoms.

10 Oct 2011

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

Medtronic, Inc. today announced results from its Tailored Treatment of Permanent Atrial Fibrillation clinical trial, the first randomized study comparing ablation therapy with the Medtronic Phased RF Ablation System ablation system to traditional medical management in 210 patients with persistent or long-standing persistent atrial fibrillation.

From Medtronic 10 Oct 2011

Novo Nordisk introduces new disposable prefilled insulin pen

Novo Nordisk has today announced the launch of their new disposable prefilled insulin pen - FlexTouch - in the UK. FlexTouch is available in the UK with Novo Nordisk's rapid-acting modern insulin analogue NovoRapid.

From Novo Nordisk 10 Oct 2011

AAD applauds California for prohibiting indoor tanning device use among youngsters

Today California Governor Edmund G. Brown signed a bill into law that will prohibit the use of indoor tanning devices for all Californians under the age of 18.

10 Oct 2011

Scientists identify 16M SNPs that associate with risk of gout, serum uric acid levels

Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA report the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels.

10 Oct 2011

FARA announces 2011 Ataxian Athlete Initiative grant recipients

The Friedreich's Ataxia Research Alliance (FARA), in partnership with The FA Project, Catrike, Anna Maria Oyster Bar, and The Melting Pot are pleased to announce Bill Ramsey, Tom Trovinger, Mary Vida, and Patrick Cogan as the 2011 Ataxian Athlete Initiative (AAI) grant recipients.

10 Oct 2011

Scientists identify first DNA faults linked to melanoma

Cancer Research UK scientists have discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour, according to research published in Nature Genetics today.

10 Oct 2011

Researchers examine effects of antirejection drugs in kidney transplant patients

Modern medicine's ability to save lives through organ transplantation has been revolutionized by the development of drugs that prevent the human body from rejecting the transplanted organ.

10 Oct 2011

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions.

10 Oct 2011

Medical Condition News

Four-gene signature may predict patients at higher risk of OSCC recurrence

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Case Western Reserve wins NCI grant to study genetic determinants of esophageal cancer

FDA to review Banner's Bexarotene ANDA for CTCL skin cancer treatment

Rare and severe hypoglycemia could be genetic

Merck’s diabetes combo pill gets FDA nod

Targacept commences AZD3480 Phase 2b study in Alzheimer’s disease

Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance

AIM at Melanoma applauds bill banning children from using indoor tanning beds

Ford researchers develop series of in-car health and wellness apps, services

Beauty Encounter sponsors ACS's premier breast cancer event

Cannabis use leads to increased risk of depression in young people with specific genotype

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

Novo Nordisk introduces new disposable prefilled insulin pen

AAD applauds California for prohibiting indoor tanning device use among youngsters

Scientists identify 16M SNPs that associate with risk of gout, serum uric acid levels

FARA announces 2011 Ataxian Athlete Initiative grant recipients

Scientists identify first DNA faults linked to melanoma

Researchers examine effects of antirejection drugs in kidney transplant patients

New siRNA treatment reduces damaging inflammation in animals models of several disorders

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News